A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
X-linked recessive myotubular myopathy (MTM1) is characterized by severe hypotonia and generalized muscle weakness, with impaired maturation of muscle fibres. We have restricted the candidate region to 280 kb and characterized two candidate genes using positional cloning strategies. The presence of frameshift or missense mutations (of which two are new mutations) in seven patients proved that one of these genes is indeed implicated in MTM1. The protein encoded by the MTM1 gene is highly conserved in yeast, which is surprising for a muscle specific disease. The protein contains the consensus sequence for the active site of tyrosine phosphatases, a wide class of proteins involved in signal transduction. At least three other genes, one located within 100 kb distal from the MTM1 gene, encode proteins with very high sequence similarities and define, together with the MTM1 gene, a new family of putative tyrosine phosphatases in man.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The XLMTM is caused by mutations in the myotubularin 1 (MTM1) gene, located at Xq28.31”
From Current clinical applications of in vivo gene therapy with AAVs (2021) · cites this paper as [31]
In the citing paper
“Furthermore, mounting evidence shows that autophagy is regulated by distinct mechanisms in different cell types [11–26], and these cell type-specific mechanisms underlie the differential vulnerability of separate tissues to autophagy mutations, resulting in heterogenous manifestations of disease.”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [17]
In the citing paper
“For instance, centronuclear myopathy is caused by mutations in the genes encoding MTM1 (myotubularin1) or MTMR14/Jumpy (myotubularin related protein 14) [17,20].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [17]
In the citing paper
“These loss-of-function mutations prevent these enzymes from metabolizing phosphoinositides required for autophagy, thereby disinhibiting autophagy flux and muscle atrophy [17,20].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [17]
Citations
Cites
Basic local alignment search tool
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990) · Journal of Molecular Biology · doi:10.1006/jmbi.1990.9999 · Cited by 98,669
A simple salting out procedure for extracting DNA from human nucleated cells
Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.3.1215 · Cited by 20,330
Bronner, C. E., Baker, S. M., Morrison, P. T., Warren, G., Smith, L. G., Lescoe, M. K., Kane, M., Earabino, C., Lipford, J., Lindblom, A., et al. (1994) · Nature · doi:10.1038/368258a0 · Cited by 2,052
2.2 Mb of contiguous nucleotide sequence from chromosome III of C. elegans
Wilson, R., Ainscough, R., Anderson, K., Baynes, C., Berks, M., Bonfield, J., Burton, J., Connell, M., Copsey, T., Cooper, J., et al. (1994) · Nature · doi:10.1038/368032a0 · Cited by 1,465
Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters
Mosser, J., Douar, A.-M., Sarde, C.-O., Kioschis, P., Feil, R., Moser, H., Poustka, A.-M., Mandel, J.-L., & Aubourg, P. (1993) · Nature · doi:10.1038/361726a0 · Cited by 1,202
Self-citationProtein Tyrosine Phosphatases: A Diverse Family of Intracellular and Transmembrane Enzymes
Fischer, E. H., Charbonneau, H., & Tonks, N. K. (1991) · Science · doi:10.1126/science.1650499 · Cited by 956
Locating protein-coding regions in human DNA sequences by a multiple sensor-neural network approach.
Uberbacher, E. C., & Mural, R. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11261 · Cited by 652
Sigma factors from E. coli, B. subtilis, phage SP01, and phage T4 are homologous proteins
Gribskov, M., & Burgess, R. R. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.16.6745 · Cited by 445
Hormones, Growth Factors, and Myogenic Differentiation
Florini, J. R., Ewton, D. Z., & Magri, K. A. (1991) · Annual Review of Physiology · doi:10.1146/annurev.ph.53.030191.001221 · Cited by 423
Exon amplification: a strategy to isolate mammalian genes based on RNA splicing.
Buckler, A. J., Chang, D. D., Graw, S. L., Brook, J. D., Haber, D. A., Sharp, P. A., & Housman, D. E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.4005 · Cited by 420
Research works printed but not linked: 1
- Lanfranchi, G. et al. Identification of 4,370 expressed sequence tags (ESTs) from a 3′-end specific cDNA library of human skeletal muscle by DNA sequencing and fitter hybridization. Genome Res. (in the press).
Cited by
Items 301–400 of 654
Dupont, J.-B., Guo, J., Renaud-Gabardos, E., Poulard, K., Latournerie, V., Lawlor, M. W., Grange, R. W., Gray, J. T., Buj‐Bello, A., Childers, M. K., et al. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.10.018 · Cited by 30
“XLMTM is a centronuclear myopathy caused by mutations in the MTM1 gene, which encodes the myotubularin protein.(17) Patients exhibit severe muscle weakness, breathing difficulties,”
BackgroundMyostatin: a Circulating Biomarker Correlating with Disease in Myotubular Myopathy Mice and Patients
Koch, C., Buono, S., Menuet, A., Robé, A., Djeddi, S., Kretz, C., Gómez, R., Depla, M., Monseur, A., Thielemans, L. A., et al. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.04.022 · Cited by 29
Self-citationDorchies, O. M., Laporte, J., Wagner, S., Hindelang, C., Warter, J., Mandel, J., & Poindron, P. (2001) · Neuromuscular Disorders · doi:10.1016/s0960-8966(01)00221-8 · Cited by 29
“MTM1, the gene implicated in XLMTM has been identified in 1996 [4], improving the efficiency of pre- and postnatal diagnosis and genetic counselling.”
BackgroundSelf-citationThe systematic functional characterisation of Xq28 genes prioritises candidate disease genes
Kolb‐Kokocinski, A., Mehrle, A., Bechtel, S., Simpson, J. C., Kioschis, P., Wiemann, S., Wellenreuther, R., & Poustka, A. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-29 · Cited by 29
“Among them Xlinked adrenoleukodystrophy (ALD, OMIM #300100, [9]), X-linked myotubular myopathy (MTM1, OMIM #310400, [10]), X-linked Dyskeratosis Congenita (DKC1, OMIM #305000, [11]), and Rett Syndrome (MECP2, OMIM #312750, [12]).”
BackgroundSelf-citationJames, N. G., Digman, M. A., Ross, J. A., Baryłko, B., Wang, L., Li, J., Chen, Y., Mueller, J. D., Gratton, E., Albanesi, J. P., et al. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.09.001 · Cited by 28
“These proteins include myotubularin, associated with an X-linked form of the disease [4], Bin1/amphiphysin 2, associated with an autosomal recessive form [5], and dynamin 2 (Dyn2), the protein investigated in this study and responsible for most known autosomal dominant forms of CNM [6].”
BackgroundBIN1, Myotubularin, and Dynamin-2 Coordinate T-Tubule Growth in Cardiomyocytes
Perdreau‐Dahl, H., Lipsett, D. B., Frisk, M., Kermani, F., Carlson, C. R., Brech, A., Shen, X. M., Bergan-Dahl, A., Hou, Y., Tuomainen, T., et al. (2023) · Circulation Research · doi:10.1161/circresaha.122.321732 · Cited by 33
Self-citationMuscle function in A canine model of X‐linked myotubular myopathy
Grange, R. W., Doering, J., Mitchell, E. L., Holder, M., Guan, X., Goddard, M. A., Tegeler, C. J., Beggs, A. H., & Childers, M. K. (2012) · Muscle & Nerve · doi:10.1002/mus.23463 · Cited by 27
Ding, Y., Ndamukong, I., Zhao, Y. Y., Xia, Y., Riethoven, J.-J. M., Jones, D. R., Divecha, N., & AVRAMOVA, Z. V. (2012) · The Plant Journal · doi:10.1111/j.1365-313x.2012.04936.x · Cited by 27
“Keywords: Arabidopsis MTM1, MTM2, plant myotubularins, evolution.”
Nuclear defects in skeletal muscle from a Dynamin 2-linked centronuclear myopathy mouse model
Fongy, A., Falcone, S., Lainé, J., Prudhon, B., Martins-Bach, A. B., & Bitoun, M. (2019) · Scientific Reports · doi:10.1038/s41598-018-38184-0 · Cited by 28
Wang, Z., Wilkop, T., Han, J. H., Dong, Y., Linman, M. J., & Cheng, Q. J. (2008) · Analytical Chemistry · doi:10.1021/ac800845w · Cited by 26
Kioschis, P., Wiemann, S., Heiss, N. S., Francis, F., Götz, C., Poustka, A., Taudien, S., Platzer, M., Wiehe, T., Beckmann, G., et al. (1998) · Genomics · doi:10.1006/geno.1998.5560 · Cited by 26
Self-citationHoffman, B. T., Nelson, M., Burdick, K. W., & Baxter, S. M. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043452659 · Cited by 27
“Mutations in myotubularin itself cause X-linked myotubular myopathy, [178, 179] and mutations in myotubularin related protein 2 cause type 4B1 Charcot-Marie-Tooth disease.”
BackgroundUpdate on Congenital Myopathies in Adulthood
Papadimas, G. K., Xirou, S., Kararizou, E. G., & Papadopoulos, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103694 · Cited by 25
Calcium homeostasis alterations in a mouse model of the Dynamin 2-related centronuclear myopathy
Fraysse, B., Guicheney, P., & Bitoun, M. (2016) · Biology Open · doi:10.1242/bio.020263 · Cited by 27
“The X-linked recessive myotubular myopathy (XLMTM), characterized by severe hypotonia and generalized muscle weakness at birth, is caused by mutations in the MTM1 gene encoding the myotubularin (Laporte et al., 1996).”
BackgroundThe Myotubularin Family: Novel Phosphoinositide Regulators
Nandurkar, H. H., & Huysmans, R. D. (2002) · IUBMB Life · doi:10.1080/15216540210812 · Cited by 29
Flex, E., Luca, A. D., D’Apice, M. R., Buccino, A., Dallapiccola, B., & Novelli, G. (2002) · Neuromuscular Disorders · doi:10.1016/s0960-8966(01)00328-5 · Cited by 25
Gene expression analyses in X-linked myotubular myopathy
Noguchi, S., Fujita, M., Murayama, K., Kurokawa, R., & Nishino, I. (2005) · Neurology · doi:10.1212/01.wnl.0000174625.67484.4d · Cited by 26
Joubert, R., Vignaud, A., Le, M., Moal, C., Messaddeq, N., & Buj-Bello, A. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt038 · Cited by 24
“The disease is due to loss-of-function mutations in the ubiquitously expressed MTM1 gene that encodes a phosphoinositide phosphatase named myotubularin (6).”
BackgroundBertini, E., Biancalana, V., Bolino, A., Buj‐Bello, A., Clague, M. J., Guicheney, P., Jungbluth, H., Kress, W., Musarò, A., Nandurkar, H. H., et al. (2004) · Neuromuscular Disorders · doi:10.1016/j.nmd.2004.04.002 · Cited by 30
Self-citationPhosphatidylinositolphosphate phosphatase activities and cancer
Rudge, S. A., & Wakelam, M. J. O. (2015) · Journal of Lipid Research · doi:10.1194/jlr.r059154 · Cited by 25
Implication of phosphoinositide phosphatases in genetic diseases: the case of myotubularin
Tronch�re, H., Buj‐Bello, A., Mandel, J., & Payrastre, B. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3062-3 · Cited by 28
Self-citationBornemann, A., & Goebel, H. H. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00393.x · Cited by 27
“The MTM1 gene is ubiquitously expressed in all human tissues, however, a smaller transcript, the expression of which is restricted to skeletal muscle and testis, has also been identified (47).”
BackgroundInfluentialNeuromuscular Disorders in the Newborn
Darras, B. T. (1997) · Clinics in Perinatology · doi:10.1016/s0095-5108(18)30152-0 · Cited by 25
Hunter, J. M., Kiefer, J., Balak, C. D., Jooma, S., Ahearn, M. E., Hall, J. G., & Baumbach-Reardon, L. L. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36934 · Cited by 26
Volpatti, J. R., Ghahramani-Seno, M. M., Mansat, M., Sabha, N. S., Sarikaya, E., Goodman, S. J., Chater‐Diehl, E., Celik, A., Pannia, E., Froment, C., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02468-7 · Cited by 25
“X-linked myotubular myopathy (XLMTM) is a rare neuromuscular disorder caused by loss-of-function mutation in the MTM1 gene [38].”
Translational medicine in neuromuscular disorders: from academia to industry
Cowling, B. S., & Thielemans, L. A. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.041434 · Cited by 25
Striated Preferentially Expressed Protein Kinase (SPEG) in Muscle Development, Function, and Disease
Luo, S., Rosen, S. M., Li, Q.-F., & Agrawal, P. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115732 · Cited by 20
MTM1 gene mutations in Japanese patients with the severe infantile form of myotubular myopathy
Nishino, I., Minami, N., Kobayashi, O., Ikezawa, M., Goto, Y., Arahata, K., & Nonaka, I. (1998) · Neuromuscular Disorders · doi:10.1016/s0960-8966(98)00075-3 · Cited by 24
“[2]) and 5′-ATGTTAGTTCAAGTTCTACATGGAGGC-3′ (nt 1983–1957), 2.”
BackgroundInfluentialMyopathy in a woman and her daughter associated with a novel splice site MTM1 mutation
Hedberg, C., Lindberg, C., Máthé, G., Moslemi, A., & Oldfors, A. (2011) · Neuromuscular Disorders · doi:10.1016/j.nmd.2011.10.010 · Cited by 24
A Study of a Cohort of X-Linked Myotubular Myopathy at the Clinical, Histologic, and Genetic Levels
Neto, O. L. A., Silva, M. R. E., Moreno, C. A. M., Oliveira, A. S. B., Reed, U. C., Biancalana, V., Pesquero, J. B., Laporte, J., & Zanoteli, E. (2016) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2016.01.023 · Cited by 23
Self-citationDjeddi, S., Reiss, D. J., Menuet, A., Freismuth, S., Neves, J. D. C., Djerroud, S., Massana-Muñoz, X., Sosson, A.-S., Kretz, C., Raffelsberger, W., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.04.033 · Cited by 26
Self-citationNatural history of a mouse model of X-linked myotubular myopathy
Sarikaya, E., Sabha, N. S., Volpatti, J. R., Pannia, E., Maani, N., Gonorazky, H. D., Celik, A., Liang, Y., Onofre-Oliveira, P. C. G., & Dowling, J. J. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049342 · Cited by 24
“MTM1 is a lipid phosphatase that acts on phosphoinositides (PIPs) (Laporte et al., 1996; Raess et al., 2017); specifically, it dephosphorylates (and thus deactivates) PI3P and PI3,5P2, and through this action also generates PI5P (Blondeau et al., 2000; Taylor et al., 2000; Volpatti et al., 2019).”
Orthopaedic Complications of Myotubular Myopathy
Cahill, P. J., Rinella, A., & Bielski, R. J. (2007) · Journal of Pediatric Orthopaedics · doi:10.1097/bpo.0b013e31802b6c73 · Cited by 23
“The second postulates a failure of myogenesis.(4) The genetic mode of inheritance can be X-linked recessive or, more rarely, autosomal recessive or dominant.”
Vincent, M., Guiraud-Chaumeil, C., Laporte, J., Manouvrier‐Hanu, S., & Mandel, J. (1998) · Journal of Medical Genetics · doi:10.1136/jmg.35.3.241 · Cited by 23
Self-citationDiagnosing X-linked Myotubular Myopathy – A German 20-year Follow Up Experience
Gangfuß, A., Schmitt, D., Roos, A., Braun, F., Annoussamy, M., Servais, L., & Schara, U. (2020) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-200539 · Cited by 23
“Until now only small case series concentrate on MTM1 molecular genetics and associated clinical phenotypes [15, 16], which is why the need for a larger cohort to unravel potential statistically significant correlations remains.”
BackgroundBuscara, L., Gross, D., & Danièle, N. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10040258 · Cited by 23
Asif, M., Kaygusuz, E., Shinawi, M. S., Nickelsen, A., Hsieh, T., Wagle, P., Budde, B. S., Hochscherf, J., Abdullah, U., Höning, S., et al. (2022) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2022.100111 · Cited by 26
The role of myotubularin-related phosphatases in the control of autophagy and programmed cell death
Zou, J., Majerus, P. W., Wilson, D. B., Schrade, A., Chang, S.-C., & Wilson, M. P. (2011) · Advances in Biological Regulation · doi:10.1016/j.advenzreg.2011.10.001 · Cited by 21
“The gene encoding this phosphatase was isolated by positional cloning of the gene mutated in Xlinked myotubular myopathy (Laporte et al., 1996).”
Mercier, L., Böhm, J., Fekonja, N., Allio, G., Lutz, Y., Koch, M., Goetz, J. G., & Laporte, J. (2016) · IntraVital · doi:10.1080/21659087.2016.1168553 · Cited by 21
Self-citationThe Roles of Pseudophosphatases in Disease
Mattei, A. M., Smailys, J., Hepworth, E. M. W., & Hinton, S. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136924 · Cited by 23
“Mutants of another pseudophosphatase myotubularin 1 (MTM1), distinctively different from MTMR1, lead to XLCNM [78].”
BackgroundInfluentialCasar‐Borota, O., Jacobsson, J., Libelius, R., Oldfors, C. H., Malfatti, E., Romero, N. B., & Oldfors, A. (2015) · Neuromuscular Disorders · doi:10.1016/j.nmd.2015.01.001 · Cited by 21
“Mutations in the myotubularin-1 (MTM1) gene cause a severe neonatal X-linked myotubular myopathy, or a sporadic, late-onset CNM characterised by nuclear internalisation and necklace fibres in many cases [1,7–9].”
BackgroundNovel SPEG mutations in congenital myopathies: Genotype–phenotype correlations
Qualls, A., Donkervoort, S. C., Herkert, J. C., D’Gama, A. M., Bharucha-Goebel, D. X., Collins, J. J., Chao, K. R., Foley, A. R., Schoots, M. H., Jongbloed, J. D. H., et al. (2018) · Muscle & Nerve · doi:10.1002/mus.26378 · Cited by 21
“Nevertheless, the divergent results in earlier genetic screening studies in patients with idiopathic SFN suggest that, in some populations, screening for these disorders may be worthwhile.(6,10) The authors thank Dr.”
known, I. T. G. C. A. N. D. I., Usually, D. M. D. C. B. P. B. M. A. O. D. F. T. A. I. I. R., type, E. W. A. K. T. H. M. I. T. P. D. W. B. A. F. D. W. H. B. E. F. P. B. L. B. P. D. O. I., electrophoresis, T. M. W. T. B. D. E. D. B. G., gene, D. B. R. E. O. B. D. S. I. A. G. I. V. L. (. W. M. T. 3. E. A. N. U. A. M. A. S. T. T. E., cases, D. M. A. C. B. V. C. A. T.-C. I. T., Gené, R., CADASIL, W. M. M. B. C. E. G. I., & gene)., W. 7. O. M. A. F. I. E. 3. A. 4. O. T. N. (2001) · European Journal of Neurology · doi:10.1046/j.1468-1331.2001.00226.x · Cited by 21
Members of the task force on molecular diagnosis of neurologic disorders: T. Gasser, G. M. D. (2001) · European Journal of Neurology · doi:10.1046/j.1468-1331.2001.00228.x · Cited by 23
Bruno, C., & Minetti, C. (2004) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-004-0015-7 · Cited by 21
Are other protein tyrosine phosphatases than PTPN22 associated with autoimmunity?
Mustelin, T. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.03.013 · Cited by 20
Carnivore-Specific SINEs (Can-SINEs): Distribution, Evolution, and Genomic Impact
Walters-Conte, K., Johnson, D. L. E., Allard, M. W., & Pecon‐Slattery, J. (2011) · Journal of Heredity · doi:10.1093/jhered/esr051 · Cited by 21
“The disease is characterized by muscle weakness, muscular atrophy, and other afflictions attributed to compromised muscle fibers (Hu et al. 1996; Laporte et al. 1996).”
BackgroundStarza, R. L., Crescenzi, B., Pierini, V., Romoli, S., Gorello, P., Brandimarte, L., Matteucci, C., Kropp, M. G., Barba, G., Martelli, M. F., et al. (2007) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2007.01.011 · Cited by 20
Danièle, N., Moal, C., Julien, L., Marinello, M., Jamet, T., Martin, S., Vignaud, A., Lawlor, M. W., & Buj‐Bello, A. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly002 · Cited by 21
Germline mosaicism in X‐linked myotubular myopathy
Häne, B., Rogers, R. C., & Schwartz, C. E. (1999) · Clinical Genetics · doi:10.1034/j.1399-0004.1999.560111.x · Cited by 20
“These mutations cause amino acid substitutions within the proposed tyrosine phosphatase domain of myotubularin (13, 15, 16), and presumably reduce or abolish tyrosine phosphatase activity.”
BackgroundMethodInfluential72nd ENMC International Workshop: Myotubular Myopathy 1–3 October 1999, Hilversum, The Netherlands
Wallgren‐Pettersson, C. (2000) · Neuromuscular Disorders · doi:10.1016/s0960-8966(00)00124-3 · Cited by 20
DNM2 mutations in a cohort of sporadic patients with centronuclear myopathy
Neto, O. L. A., Moreno, C. A. M., Carvalho, M. S., Chadi, G., Seitz, K. W., Oliveira, A. S. B., Reed, U. C., Laporte, J., & Zanoteli, E. (2015) · Genetics and Molecular Biology · doi:10.1590/s1415-4757382220140238 · Cited by 19
“Three inheritance patterns are described: (i) X-linked recessive, which gives rise to a form also referred to as myotubular myopathy (MIM #310400), with a severe neonatal presentation marked by profound hypotonia and respiratory failure; this pattern is associated with the MTM1 gene (MIM *300415) (Laporte et al., 1996…”
BackgroundSelf-citationWalmsley, G., Blot, S., Venner, K., Sewry, C. A., Laporte, J., Blondelle, J., Barthélémy, I., Maurer, M., Blanchard‐Gutton, N., Pilot‐Storck, F., et al. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.10.002 · Cited by 19
Self-citationThe PTEN and Myotubularin Phosphoinositide 3-Phosphatases: Linking Lipid Signalling to Human Disease
Davies, E. M., Sheffield, D. A., Tibarewal, P., Fedele, C. G., Mitchell, C. A., & Leslie, N. R. (2012) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-3012-0_8 · Cited by 19
Tamoxifen improves muscle structure and function of Bin1- and Dnm2-related centronuclear myopathies
Gineste, C., Simon, A., Braun, M., Reiss, D. J., & Laporte, J. (2022) · Brain · doi:10.1093/brain/awac489 · Cited by 18
Self-citationNovel SPEG Mutations in Congenital Myopathy without Centralized Nuclei
Lornage, X., Sabouraud, P., Lannes, B., Gaillard, D. A., Schneider, R., Deleuze, J., Boland, A., Thompson, J., Böhm, J., Biancalana, V., et al. (2018) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-170265 · Cited by 18
Self-citationAppel, S., Filter, M., Reis, A., Hennies, H. C., Bergheim, A., Ogilvie, E., Arndt, S., Simmons, A. D., Lovett, M., Hide, W., et al. (2002) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200750 · Cited by 18
Nemaline and myotubular myopathies
Wallgren‐Pettersson, C. (2002) · Seminars in Pediatric Neurology · doi:10.1053/spen.2002.33804 · Cited by 18
MTM1 overexpression prevents and reverts BIN1-related centronuclear myopathy
Giraud, Q., Spiegelhalter, C., Messaddeq, N., & Laporte, J. (2023) · Brain · doi:10.1093/brain/awad251 · Cited by 19
Self-citationPhosphoinositide substrates of myotubularin affect voltage-activated Ca2+ release in skeletal muscle
Rodríguez, E. G., Lefebvre, R., Bodnár, D., Legrand, C., Szentesi, P., Vincze, J., Poulard, K., Bertrand‐Michel, J., Csernoch, L. J., Buj‐Bello, A., et al. (2013) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-013-1346-5 · Cited by 17
“However, recent data from transgenic models of PtdInsP -phosphatase deficiency, specifically MTM1 (myotubularin) and parent proteins ("myotubularin and myopathy related" phosphatases [MTMRs]; see [3]) provided completely unanticipated insights into the field: in humans, more than 200 mutations of the gene encoding MTM…”
BackgroundSome DNM2 mutations cause extremely severe congenital myopathy and phenocopy myotubular myopathy
Biancalana, V., Romero, N. B., Thuestad, I. J., Ignatius, J., Kataja, J., Gardberg, M., Héron, D., Malfatti, E., Oldfors, A., & Laporte, J. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0593-2 · Cited by 17
Self-citationTherapeutic Aspects in Congenital Myopathies
Jungbluth, H., & Muntoni, F. (2019) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2019.01.004 · Cited by 19
“With X-linked myotubular myopathy (XLMTM) due to X-linked recessive mutations in myotubularin 13 , the CNMs include one of the most severe CMs, with marked hypotonia and bulbar involvement, profound respiratory impairment often necessitating supportive ventilation and associated with high mortality.”
BackgroundReumers, S. F. I., Braun, F., Spillane, J. E., Böhm, J., Pennings, M., Schouten, M. I., van der Kooi, A. J., Foley, A. R., Bönnemann, C. G., Kamsteeg, E., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012236 · Cited by 20
Massana-Muñoz, X., Goret, M., Nattarayan, V., Reiss, D. J., Kretz, C., Chicanne, G., Payrastre, B., Vanhaesebroeck, B., & Laporte, J. (2023) · JCI Insight · doi:10.1172/jci.insight.151933 · Cited by 17
“PtdIns3P is the main substrate of myotubularin, while PtdIns(3,4)P2 is not a recognized substrate (11) (Figure 5C).”
BackgroundInfluentialSelf-citationYamaguchi, S., Homma, K., & Natori, S. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00143.x · Cited by 17
Ca2+-induced sarcoplasmic reticulum Ca2+ release in myotubularin-deficient muscle fibers
Kutchukian, C., Szentesi, P., Allard, B., Buj‐Bello, A., Csernoch, L. J., & Jacquemond, V. (2019) · Cell Calcium · doi:10.1016/j.ceca.2019.04.004 · Cited by 17
Lexikon der Syndrome und Fehlbildungen
Witköwski, R., Prokop, O., & Ullrich, E. (1999) · Springer eBooks · doi:10.1007/978-3-642-98007-7_6 · Cited by 17
Genetics of the nemaline myopathies and the myotubular myopathies
Wallgren‐Pettersson, C. (1998) · Neuromuscular Disorders · doi:10.1016/s0960-8966(98)00045-5 · Cited by 17
Gait characteristics in a canine model of X-linked myotubular myopathy
Goddard, M. A., Burlingame, E., Beggs, A. H., Buj‐Bello, A., Childers, M. K., Marsh, A. P., & Kelly, V. E. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.08.032 · Cited by 17
“XLMTM is caused by the absence of the phosphoinositide phosphatase myotubularin due to mutation of the MTM1 gene on the long arm of the X chromosome [5].”
Eps 15 Homology Domain (EHD)-1 Remodels Transverse Tubules in Skeletal Muscle
Demonbreun, A. R., Swanson, K. E., Rossi, A. E., Deveaux, H. K., Earley, J. U., Allen, M. V., Arya, P., Bhattacharyya, S., Band, H., Pytel, P., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136679 · Cited by 18
“Myotubularin is a phosphoinositide phosphatase, and loss of functionMTM1mutations also cause myopathy [1].”
BackgroundProtein tyrosine phosphatases as drug targets: PTP1B and beyond
van Huijsduijnen, R. H., Wälchli, S., Ibberson, M. R., & Harrenga, A. (2002) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.6.6.637 · Cited by 21
“MTM-1 Human mutations: severe hypotonia and generalised muscle weakness*2 [71]”
BackgroundO’Connor, T. N., van den Bersselaar, L. R., Chen, Y. S., Nicolau, S., Simon, B., Huseth, A., Todd, J. J., Petegem, F. V., Sárközy, A., Goldberg, M. F., et al. (2022) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-221609 · Cited by 18
Novel SPEG variant cause centronuclear myopathy in China
Tang, J., Ma, W., Chen, Y., Jiang, R., Zeng, Q., Tan, J., Jiang, H., Li, Q., Zhang, V. W., Wang, J., et al. (2019) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23054 · Cited by 15
Jungbluth, H., Wallgren‐Pettersson, C., & Laporte, J. (2009) · Neuromuscular Disorders · doi:10.1016/j.nmd.2009.06.373 · Cited by 15
Self-citationRole of dynamin 2 in the disassembly of focal adhesions
Briñas, L., Vassilopoulos, S., Bonne, G., Guicheney, P., & Bitoun, M. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1040-2 · Cited by 15
“Mutations in the DNM2 gene also cause autosomal dominant CNM [12], a slowly progressive congenital myopathy.”
BackgroundInfluentialCondition-dependent functional shift of two Drosophila Mtmr lipid phosphatases in autophagy control
Manzéger, A., Tagscherer, K., Lőrincz, P., Szaker, H. M., Lukácsovich, T., Pilz, P., Kméczik, R., Csikós, G., Erdélyi, M., Sass, M., et al. (2021) · Autophagy · doi:10.1080/15548627.2021.1899681 · Cited by 16
“The discovery of human MTMRs was strongly linked to various muscle and neurodegenerative pathologies such as myotubular myopathy and Charcot-Marie-Tooth disease [1,4,5].”
BackgroundFirestein, R., Nagy, P. L., Daly, M. E., Huie, P., Conti, M., & Cleary, M. L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200212589 · Cited by 15
External ophthalmoplegia in neuromuscular disorders: Case report and review of the literature
Jones, K. J., & North, K. N. (1997) · Neuromuscular Disorders · doi:10.1016/s0960-8966(97)00447-1 · Cited by 15
Algorithms and software for support of gene identification experiments.
Sze, S., Абрамович, Р. М., Gelfand, M. S., Mironov, A. A., Astakhova, T. V., & Pevzner, P. A. (1998) · Bioinformatics · doi:10.1093/bioinformatics/14.1.14 · Cited by 15
“Computer predictions were also used to perform single-strand conformation polymorphism mutation analysis in X-linked myotubular myopathy (Laporte et al., 1996).”
MethodMicroRNA-130a is highly expressed in the esophageal mucosa of achalasia patients
Shoji, H., Isomoto, H., Yoshida, A., Ikeda, H., Minami, H., Kanda, T., Urabe, S., Matsushima, K., Takeshima, F., Nakao, K., et al. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4598 · Cited by 14
“The myotubularin gene (MTM1) was identified as a gene mutated in X-linked myotubular myopathy (37).”
Genetic therapy for congenital myopathies
Maani, N., Karolczak, S., & Dowling, J. J. (2021) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000978 · Cited by 15
“An ASO targeting human DNM2 has now entered clinical trial for XLMTM and DNM2 related CNM (NCT04033159). r Health, Inc.”
BackgroundInfluentialSignaling and the Polyphosphoinositide Phosphatases from Plants
Gillaspy, G. E. (2009) · Plant cell monographs · doi:10.1007/978-3-642-03873-0_8 · Cited by 14
Cloning of Novel Trinucleotide-Repeat (CAG) Containing Genes in Mouse Brain
Kim, S. J., Shon, B. H., Kang, J. H., Hahm, K., Yoo, O. J., Park, Y. S., & Lee, K.-K. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7643 · Cited by 14
Hansen, L., Hansen, T. F., Clausen, J. O., Echwald, S. M., Urhammer, S. A., Rasmussen, S. K., & Pedersen, O. B. (1997) · The American Journal of Human Genetics · doi:10.1086/515464 · Cited by 14
Kawaguchi, K., & Fujita, N. (2023) · The Journal of Biochemistry · doi:10.1093/jb/mvad083 · Cited by 15
“MTM1 is the most common causative gene for X-linked myotubular myopathy (XLMTM), characterized by progressive muscle atrophy and centronuclear abnormalities (40) .”
BackgroundPhosphoinositide Metabolism: Biochemistry, Physiology and Genetic Disorders
Rossignol, F., Lamari, F., & Mitchell, G. A. (2025) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.70008 · Cited by 16
Gene therapy in monogenic congenital myopathies
Guan, X., Goddard, M. A., Mack, D. L., & Childers, M. K. (2015) · Methods · doi:10.1016/j.ymeth.2015.10.004 · Cited by 15
Myotonia in DNM2-related centronuclear myopathy
Dabby, R., Sadeh, M., Gilad, R., Jurkat‐Rott, K., Lehmann‐Horn, F., & Leshinsky‐Silver, E. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-1140-8 · Cited by 13
“X-linked myotubular myopathy is a severe disease with infantile onset, characterized by marked weakness and respiratory failure, and caused by mutations in the myotubularin gene (Laporte et al. 1996).”
BackgroundClinical and Pathological Features of Korean Patients withDNM2-Related Centronuclear Myopathy
Park, Y. E., Choi, Y., Bae, J. S., Lee, C., Kim, H.-S., Shin, J., & Kim, D. (2014) · Journal of Clinical Neurology · doi:10.3988/jcn.2014.10.1.24 · Cited by 13
Hirunagi, T., Sahashi, K., Meilleur, K. G., & Katsuno, M. (2022) · Genes · doi:10.3390/genes13010109 · Cited by 13
“X-linked myotubular myopathy (XLMTM) is a severe congenital myopathy caused by pathogenic variants in the myotubularin 1 (MTM1) gene [44,45].”
BackgroundGoddard, M. A., Mack, D. L., Czerniecki, S., Kelly, V. E., Snyder, J. M., Grange, R. W., Lawlor, M. W., Smith, B. K., Beggs, A. H., & Childers, M. K. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.10.31 · Cited by 15
“XLMTM results from lossof-function mutations in the myotubularin 1 (MTM1) gene (2), which encodes the founder of a family of 3-phosphoinositide phosphatases acting on the second messengers phosphatidylinositol 3-monophosphate [PI(3) P] and phosphatidylinositol 3,5-bisphosphate [PI(3,5)P2] (3,4).”
BackgroundX-linked myotubular myopathy due to a complex rearrangement involving a duplication of MTM1 exon 10
Trump, N., Cullup, T., Verheij, J. B. G. M., Manzur, A. Y., Muntoni, F., Abbs, S. J., & Jungbluth, H. (2011) · Neuromuscular Disorders · doi:10.1016/j.nmd.2011.11.004 · Cited by 13
“Although possible locus heterogeneity had been suggested [26] soon after the identification of the MTM1 locus on Xq28, that was subsequently refuted [27] and is probably unlikely, considering that most cases without detectable MTM1 mutations do have substantially reduced myotubularin levels [22].”
Myotubularins and associated neuromuscular diseases
Tronchère, H., Bolino, A., Laporte, J., & Payrastre, B. (2012) · Clinical Lipidology · doi:10.2217/clp.12.7 · Cited by 13
Self-citationAbundant minute myotubes in a patient who later developed centronuclear myopathy
Wöckel, L., Ketelsen, U., Stoetter, M., Laule, S., Meyermann, R., & Bornemann, A. (1998) · Acta Neuropathologica · doi:10.1007/s004010050836 · Cited by 13
Adult centronuclear myopathies: A hospital-based study
Echaniz‐Laguna, A., Biancalana, V., Böhm, J., Tranchant, C., Mandel, J., & Laporte, J. (2013) · Revue Neurologique · doi:10.1016/j.neurol.2012.12.006 · Cited by 13
Self-citationFranklin, N. E., Bonham, C. A., Xhabija, B., & Vacratsis, P. O. (2013) · Journal of Cell Science · doi:10.1242/jcs.113928 · Cited by 8
“The importance of regulating phosphoinositol phosphorylation is highlighted by the fact that loss of function mutations in three mtmr genes has been associated with distinct neuromuscular disorders (Boerkoel et al., 2002; Bolino et al., 2000; Laporte et al., 1996).”
BackgroundSit4 Phosphatase Is Functionally Linked to the Ubiquitin-Proteasome System
Singer, T., Haefner, S., Hoffmann, M., Fischer, M., Ilyina, J., & Hilt, W. (2003) · Genetics · doi:10.1093/genetics/164.4.1305 · Cited by 13
Amato, A. A., & Dumitru, D. (2002) · Elsevier eBooks · doi:10.1016/b978-1-56053-433-4.50035-3 · Cited by 18
Identification and Localization of a New Human Myotubularin-Related Protein Gene, MTMR8, on 8p22–p23
Appel, S., Reichwald, K., Zimmermann, W., Reis, A., Rosenthal, A., & Hennies, H. C. (2001) · Genomics · doi:10.1006/geno.2001.6591 · Cited by 13
“Mutations in the human myotubularin gene (MTM1) cause X-linked myotubular myopathy, a severe recessive congenital muscle disorder (XLMTM, MIM 310400 [6]).”
BackgroundGuiraud-Chaumeil, C., Vincent, M., Laporte, J., Fardeau, M., Samson, F., & Mandel, J. (1997) · The American Journal of Human Genetics · doi:10.1016/s0002-9297(07)64249-9 · Cited by 13
Self-citation
Metadata
- Authors
- Laporte, J., Hu, L. J., Kretz, C., Mandel, J.-L., Kioschis, P., Coy, J. F., Klauck, S. M., Poustka, A., & Dahl, N.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- German Cancer Research Center (DE)
- Uppsala University (SE)
- Venue
- Nature Genetics
- Published
- 1996-06
- Volume
- 13
- Issue
- 2
- Pages
- 175-182
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1984366092
- Cited by
- 639
- References
- 51
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 20 · 2023: 16 · 2022: 19 · 2021: 23 · 2020: 21 · 2019: 26 · 2018: 25 · 2017: 20 · 2016: 21 · 2015: 21 · 2014: 28 · 2013: 35 · 2012: 26
- FWCI
- 6.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- X-linked myotubular myopathy, MTM1 gene, positional cloning, frameshift mutation, missense mutations, yeast homolog, hypotonia, signal transduction, conserved protein families
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Binding Sites, Cloning, Molecular, Genes, Fungal, Humans, Genetic Linkage, Molecular Sequence Data, Muscle Hypotonia, Muscular Diseases, Mutation, Saccharomyces cerevisiae, Tissue Distribution, X Chromosome, Protein Tyrosine Phosphatases, Conserved Sequence, Caenorhabditis elegans, Protein Tyrosine Phosphatases, Non-Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.